Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any opinions on AMYT? They are generating good revenues, have an EB drug that should get approved (prirority review) and they are buying CHMA for cheap
LOL, well i am sure most of management/ownership got what they wanted.....raising money to line their pockets for years and year at the expense of shareholders. I don't doubt they will continue doing this as they eventually will announce, imo, they will continue with their program because they see some "positive" signals
No surprise..CVM trial fails. Awful spin job by them
https://finance.yahoo.com/news/cel-sci-multikine-immunotherapy-produces-132000283.html
BIIB *DEMOCRATS ANNOUNCE PROBE OF BIOGEN’S ALZHEIMER’S DRUG ADUHELM
BIIB Biogen Announces Topline Results From Phase 2 Study of Gosuranemab, an Anti-Tau Antibody, for Alzheimer’s Disease
Gosuranemab did not meet its primary efficacy endpoint
My guess is that FDA approval will be coming soon :)
ITOS lands big deal with GSK https://finance.yahoo.com/news/iteos-therapeutics-gsk-announce-development-110000722.html
Wow! A post?? Yeah, amazing potential. Going much higher
If this wasn't a giant company like BIIB, but was rather a small biotech company, would you agree they would have received a strong/harsh CRL?
Resignations over Biib approval https://www.wsj.com/articles/third-member-of-fda-advisory-panel-resigns-over-approval-of-alzheimer-drug-11623370557
AMYT no advisory meeting needed. With priority review given last week, looks like a good shot for approval https://finance.yahoo.com/news/fda-confirms-nda-oleogel-s10-110000598.html
Agreed. It seems like the fda has shifted its view on how drugs for Alzheimer’s should be assessed, no?
AMYT gets priority review https://finance.yahoo.com/news/fda-grants-priority-review-drug-060000013.html
BCTX up big right now https://finance.yahoo.com/news/briacell-reports-12-0-months-111200861.html
$MOR To Acquire $CNST For $34/Share In Cash
MRTX and $ZLAB Enter Into a Collaboration to Develop and Commercialize Adagrasib in Greater China.
$MRTX to receive an upfront payment of $65M
PRVB 10-7 vote in favor of approval reco
MYOV Relugolix approved
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
Biogen and Gingko announce “blockbuster” deal (joking) https://investors.biogen.com/news-releases/news-release-details/biogen-and-ginkgo-bioworks-announce-collaboration-and-license
pdsb looks good too https://meetinglibrary.asco.org/record/199070/abstract
ADAP abstract looks impressive. https://meetinglibrary.asco.org/record/195713/abstract
It’s been a long haul for this company. Pipeline always seemed exciting but they never executed. Looks like today longs finally got some good news
AGEN inks deal with BMY https://finance.yahoo.com/news/agenus-bristol-myers-squibb-announce-113000934.html